Naloxone hydrochlor
Ended Awarded Last action
- Contract number
- SPE2DP25F6677
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $35,832
Award facts
- Contract value 100% obligated
- $35,831.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | -$242 | |
| Original award | $36,073 |
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $35,831.51 for naloxone hydrochloride by the Defense Logistics Agency's Medical Supply Chain division. The contract, awarded on May 7, 2025, with an ultimate completion date of July 30, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
The delivery of naloxone hydrochloride supports the military's medical supply chain requirements for this critical emergency medication used to reverse opioid overdoses. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain through consistent contract performance delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities. The company's role as a primary distributor through the SPE2DB program underscores its importance in maintaining pharmaceutical readiness across the Defense Department's healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DP25F6677?
SPE2DP25F6677 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on May 7, 2025.
How much is contract SPE2DP25F6677 worth?
The government has obligated $35,832 on SPE2DP25F6677.
Is contract SPE2DP25F6677 an order under another contract?
Yes. SPE2DP25F6677 is a delivery order under SPE2DX15D9383, an indefinite delivery contract.
Was contract SPE2DP25F6677 competed?
The extent of competition for SPE2DP25F6677 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award